Cannabinoids in Neurologic and Mental Disease

Specificaties
Gebonden, blz. | Engels
Elsevier Science | e druk, 2015
ISBN13: 9780124170414
Rubricering
Juridisch :
Elsevier Science e druk, 2015 9780124170414
€ 137,80
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Samenvatting

The application of cannabis sativa for the treatment of neurologic and mental disease is expanding. Cannabinoids in Neurologic and Mental Disease collects and presents for the first time recent research involving the use of pharmacological cannabinoids for the treatment of neurodegenerative and neuroinflammatory disease. The neurologic application of cannabinoid therapy builds upon psychiatric and psychological use for the treatment of a variety of core mental disorders. This comprehensive reference on the known uses of cannabinoids will be useful for clinical neurologists, neuroscience and clinical neuroscience researchers, clinical psychologists and psychiatrists and the general medical community.

Specificaties

ISBN13:9780124170414
Taal:Engels
Bindwijze:Gebonden

Inhoudsopgave

<p>The ever expanding world of the endocannabinoids: a concise introduction - Fabiana Piscitelli and Vincenzo Di Marzo </p> <p>PART I: ROLE OF THE ENDOCANNABINOIDS IN NEUROINFLAMMATORY AND NEURODEGENERATIVE DISORDERS <br>1. Cannabinoids for the treatment of Neuroinflammation - Maria L. de Ceballos<br>2. Endocannabinoids and Alzheimer's Disease - Steven George Fagan and Veronica A. Campbell <br>3. Cannabinoids in Parkinson's Disease - Eilís Dowd<br>4. Cannabinoids and Huntington's Disease - Cindy Casteels, Rawaha Ahmad, Matheiu Vandenbulcke, Wim Vandenberghe and Koen Van Laere <br>5. Endocannabinoids and Amyotrophic Lateral Sclerosis - Eva de Lago, Miguel Moreno-Martet, Francisco Espejo-Porras and Javier Fernández-Ruiz <br>6. Endocannabinoids and Epilepsy - Robert E. Blair, Laxmikant Deshpande and Robert J. DeLorenzo <br>7. Endocannabinoids and Migraine - Cristina Tassorelli</p> <p>PART II:  ROLE OF THE ENDOCANNABINOIDS IN PSYCHOLOGICAL AND PSYCHIATRIC DISORDERS <br>8. Cannabinoids and Schizophrenia - Cathrin Rohleder and F. Markus Leweke <br>9. Cannabinoids and Bipolar Disorder - Raphael J. Braga, Sherif Abdelmessih, Juliana Tseng and Anil Kumar Malhotra <br>10. Cannabinoids and Tourette syndrome - Kirsten R. Müller-Vahl<br>11. The Role of Endocannabinoid Function in Posttraumatic Stress Disorder: Modulating the Risk Phenotype and Rendering Effects of Trauma - Frances H. Gabbay, Kwang H. Choi, Gary Wynn and Robert J. Ursano <br>12. Cannabinoids and Drug Addiction - Maria Antonietta De Luca and Liana Fattore <br>13. Cannabinoids and appetite (dys)regulation (Obesity) - Claire M. Williams, Benjamin J. Whalley and Ciara McCabe </p> <p>PART III:  ROLE OF THE ENDOCANNABINOIDS IN IMPULSIVE AND COMPULSIVE DISORDERS<br>14. The cannabinoid system and impulsive behavior - Joost Wiskerke and Tommy Pattij <br>15. Cannabinoids and compulsive-obsessive disorder - Plinio C. Casarotto, Felipe V. Gomes and Francisco Silveira Guimarães <br>16. The endocannabinoid system: anorexia nervosa and binge eating disorder - Maria Scherma, Valentina Satta, Walter Fratta and Paola Fadda <br>17. The Endocannabinoid System and Trichotillomania: A Promising Target for Treatment? - Jon E. Grant, Brian L. Odlaug and Samuel R. Chamberlain <br>18. CONCLUSIONS: FUTURE PERSPECTIVES Cannabinoid CB2 receptor ligands and their therapeutic potential in mental diseases - Emmanuel S. Onaivi, Hiroki Ishiguro and Qing-Rong Liu <br></p>

Net verschenen

€ 137,80
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Rubrieken

    Personen

      Trefwoorden

        Cannabinoids in Neurologic and Mental Disease